Status:
NOT_YET_RECRUITING
The Role of Noncontrast Computed Tomography Markers in Predicting the Clinical Outcome of Cerebral Hemorrhage
Lead Sponsor:
Jin Hu
Conditions:
Intracerebral Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to To investigate the ability of Noncontrast Computed Tomography to predict clinical prognosis in Intracerebral Hemorrhage. The main question it aims to answer...
Eligibility Criteria
Inclusion
- Age≥18 years
- had completed a CT examination within 24 h of disease onset;
- had a hemorrhage that was located in the brain parenchyma, including the basal ganglia, thalamus,brain lobes, brainstem, and cerebellum.
Exclusion
- had secondary ICH caused by brain trauma,cerebrovascular malformations, aneurysms, and tumors;
- had ischemic cerebral infarction hemorrhagic transformation;
- had undergone surgical treatment (e.g.hematoma removal or puncture drainage) before the CT examination;
- had images of poor quality that could notbe accurately evaluated;
- had a hematoma withborders that could not be delineated, thus precluding delineation of the region of interest (ROI).
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06535438
Start Date
August 1 2024
End Date
August 31 2024
Last Update
August 2 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.